Pharmaceuticals and the Strategic National Stockpile Program

Dental Clinics of North America

Volumn 51, Issue 4, 2007, Pages 857-869

  Stewart, Amy ^a   Cordell, Geoffrey A ^b  

^a ILLINOIS DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL DRUG;

BIOLOGICAL WARFARE; CIVIL DEFENSE; DENTIST; DISASTER PLANNING; DRUG LEGISLATION; ECONOMICS; GOVERNMENT; HEALTH CARE PLANNING; HUMAN; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; REVIEW; UNITED STATES;

BIOLOGICAL WARFARE; BIOTERRORISM; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CIVIL DEFENSE; DENTISTS; DISASTER PLANNING; DRUGS, ESSENTIAL; HUMANS; LEGISLATION, DRUG; NATIONAL HEALTH PROGRAMS; PROFESSIONAL ROLE; REGIONAL MEDICAL PROGRAMS; UNITED STATES; UNITED STATES GOVERNMENT AGENCIES;

EID: 34548643936     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2007.06.001     Document Type: Review

References (25)

1. Canter D.A. Remediating anthrax-contaminated sites: learning from the past to protect the future. Chemical Health & Safety 12 (2005) 13-19
2. Noah D.L., Huebner K.D., Darling R.G., et al. The history and threat of biological warfare and terrorism. Emerg Med Clin North Am 20 (2002) 255-271
3. In: Geissler E. (Ed). Biological and toxin weapons today (1986), Oxford University Press, Oxford (England)
4. Available at: http://en.wikipedia.org/wiki/Geneva_Protocol. Accessed February 2, 2007.
5. In: Sidell F.R., and Franz D.R. (Eds). Medical aspects of chemical and biological warfare (1997), Borden Institute, Washington, DC 1-7
6. Kaufmann A.F., Meltzer M.I., and Schmid G.P. Emerg Infect Dis 3 (1997) 83-94
7. Combating terrorism: chemical and biological medical supplies are poorly managed. GAO/HEHS/AIMD-00-36 (1999), Government Accounting Office, Washington, DC p. 26
8. Esbitt D. The strategic national stockpile: roles and responsibilities of health care professionals for receiving stockpile assets. Disaster Manag Resp 1 (2003) 68-70
9. Available at: http://www.texasjrac.org/documents/fmsfactsheet3-1.pdf. Accessed February 5, 2007.
10. Havlak R., Gorman S.E., and Adams S.A. Challenges associated with creating a pharmaceutical stockpile to respond to a terrorist event. Clin Microbiol Infect 8 (2006) 529-533
11. Terriff C.M., and Tee A.M. Citywide pharmaceutical preparation for bioterrorism. Am J Health Syst Pharm 58 (2001) 233-237
12. Bravata D.M., Zaric G.S., Holty J.-E.C., et al. Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies. Biosecur Bioterror: Biodef Strat Prac Sci 4 (2006) 244-262
13. Hsu E.B., Casani J.A., Roamnosky A., et al. Are regional hospital pharmacies prepared for public health emergencies?. Biosecur Bioterror: Biodef Strat Prac Sci 4 (2006) 237-243
14. Kaji A.H., and Lewis R.J. Hospital disaster preparedness in Los Angeles County. Acad Emerg Med 13 (2006) 1198-1203
15. Keim M.E., Pesik N., and Twum-Danso N.A. Lack of hospital preparedness for chemical terrorism in a major US city: 1996-2000. Prehospital Disaster Med 18 (2003) 193-199
16. Young D. Iowa pharmacists dispense from strategic national stockpile during drill. Am J Health Syst Pharm 60 (2003) 1304-1305
17. Beaton R.D., Oberle M.W., Wicklund J., et al. Evaluation of the Washington State National Pharmaceutical Stockpile dispensing exercise: Part I. Patient volunteer findings. J Public Health Manag Pract 9 (2003) 368-376
18. Beaton R.D., Stevermer A., Wicklund J., et al. Evaluation of the Washington State National Pharmaceutical Stockpile dispensing exercise: Part II. Dispensary site worker findings. J Public Health Manag Pract 10 (2004) 77-85
19. Cohen V. Organization of a health-system pharmacy team to respond to episodes of terrorism. Am J Health Syst Pharm 60 (2003) 1257-1263
20. Juckett G. Avian influenza: preparing for a pandemic. Am Fam Physician 74 (2006) 783-790
21. Ward P., Small I., Smith J., et al. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 55 Suppl S1 (2005) i5-i21
22. Hayden F.G. Antivirals for pandemic influenza. J Infect Dis 176 Suppl 1 (1997) S56-S61
23. Hayden F.G. Pandemic influenza: is an antiviral response realistic?. Pediatr Infect Dis J 23 (2004) S262-S269
24. Chmar J.E., Ranney R.R., Guay A.H., et al. Incorporating bioterrorism training into dental education: report of ADA-ADEA terrorism and mass casualty curriculum development workshop. J Dent Educ 68 11 (2004) 1196-1198
25. Ziskin L.Z., and Burke M.V. New Jersey State program development for terrorism preparedness and other public health emergencies. N J Med 101 9 (2004) 17